Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Novavax Shares Are Diving Today

Novavax, Inc. (NASDAQ:NVAX) shares are trading lower by 14.20% at $50.14. Bank of America's Alec Stranahan initiated coverage of Novavax with an Underperform rating and a price target of $35. Nuvaxovid is likely to underperform the longer-term consensus estimates, Stranahan said in the initiation note... Read More

Stocks have also been highly volatile following the Federal Reserve’s recent 50 basis point rate hike, which has weighed on the Nasdaq heavily.

Novavax is also trading lower by 64.92% on a year-to-date basis as investors digest the latest U.S. inflation data, which came in higher-than-expected. Anticipation of further Fed policy tightening has also continued to weigh on stocks across sectors.

See Also: Why Palo Alto Networks Stock Is Moving Higher

Novavax is a biotechnology company that develops vaccines.

According to data from Benzinga Pro, Novavax has a 52-week high of $277.80 and a 52-week low of $41.33.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.